Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
Over the last 12 months, insiders at Erasca, Inc. have bought $3.97M and sold $0 worth of Erasca, Inc. stock.
On average, over the past 5 years, insiders at Erasca, Inc. have bought $9.04M and sold $3.75M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lim Jonathan E (Chairman & CEO) — $7.44M. Casdin Alexander W. (director) — $231,705. Start Valerie Denise Harding (director) — $18,480.
The last purchase of 80,000 shares for transaction amount of $181,920 was made by Casdin Alexander W. (director) on 2024‑05‑21.
2024-05-21 | Casdin Alexander W. | director | 80,000 0.0447% | $2.27 | $181,920 | +0.43% | ||
2023-12-06 | Lim Jonathan E | Chairman & CEO | 278,150 0.1825% | $1.72 | $478,418 | +17.61% | ||
2023-12-06 | Start Valerie Denise Harding | director | 10,000 0.007% | $1.85 | $18,480 | +17.61% | ||
2023-12-05 | Lim Jonathan E | Chairman & CEO | 721,850 0.4606% | $1.69 | $1.22M | +18.34% | ||
2023-12-04 | Casdin Alexander W. | director | 30,000 0.0197% | $1.66 | $49,785 | +22.26% | ||
2023-10-05 | Lim Jonathan E | Chairman & CEO | 1M 0.695% | $2.03 | $2.03M | -0.47% | ||
2023-06-08 | Lim Jonathan E | Chairman & CEO | 100,000 0.0676% | $2.75 | $275,000 | -18.38% | ||
2023-04-10 | Casdin Alexander W. | director | 20,000 0.0135% | $2.76 | $55,230 | -14.44% | ||
2023-03-28 | Lim Jonathan E | Chairman & CEO | 100,000 0.0693% | $2.84 | $284,000 | -12.41% | ||
2023-01-10 | Lim Jonathan E | Chairman & CEO | 60,000 0.0413% | $3.86 | $231,420 | -29.33% | ||
2022-12-21 | Bristol James Arthur | director | 20,000 0.0162% | $4.14 | $82,800 | -35.48% | ||
2022-12-21 | Start Valerie Denise Harding | director | 10,000 0.0091% | $4.64 | $46,400 | -35.48% | ||
2022-12-15 | Casdin Alexander W. | director | 20,000 0.0167% | $4.87 | $97,490 | -42.71% | ||
2022-12-14 | Lim Jonathan E | Chairman & CEO | 40,000 0.0338% | $4.99 | $199,600 | -43.44% | ||
2022-12-13 | Chen Bihua | director | 307,692 0.3325% | $6.50 | $2M | -44.42% | ||
2021-08-10 | Chen Bihua | director | 200,000 0.2202% | $22.10 | $4.42M | -41.38% | ||
2021-07-26 | Sale | Chen Bihua | director | 200,000 0.2009% | $18.77 | $3.75M | -35.23% | |
2021-07-20 | Chen Bihua | director | 950,000 0.7974% | $16.00 | $15.2M | -35.39% | ||
2021-07-20 | Multani Pratik S | director | 6,200 0.0052% | $16.00 | $99,200 | -35.39% | ||
2021-07-20 | Hambleton Julie | director | 6,000 0.005% | $16.00 | $96,000 | -35.39% |
Lim Jonathan E | Chairman & CEO | 12899360 8.5377% | $2.20 | 7 | 0 | <0.0001% |
Casdin Alexander W. | director | 573974 0.3269% | $2.20 | 4 | 0 | <0.0001% |
Start Valerie Denise Harding | director | 20000 0.0132% | $2.20 | 3 | 0 | <0.0001% |
Chen Bihua | director | 10813246 7.157% | $2.20 | 3 | 1 | <0.0001% |
Multani Pratik S | director | 172866 0.1144% | $2.20 | 1 | 0 | <0.0001% |
Bristol James Arthur | director | 20000 0.0132% | $2.20 | 1 | 0 | <0.0001% |
Hambleton Julie | director | 6000 0.004% | $2.20 | 1 | 0 | <0.0001% |
Garner Ebun | General Counsel | 900 0.0006% | $2.20 | 1 | 0 | <0.0001% |
Arch Venture Management Llc | $22.77M | 4.65 | 11.06M | 0% | +$0 | 32.36 | |
BlackRock | $14.38M | 2.93 | 6.98M | -4.5% | -$678,051.10 | <0.0001 | |
Armistice Capital Llc | $12.71M | 2.59 | 6.17M | -23.77% | -$3.96M | 0.15 | |
Artal Group S A | $9.73M | 1.98 | 4.72M | 0% | +$0 | 0.05 | |
The Vanguard Group | $8.94M | 1.82 | 4.34M | +14.39% | +$1.12M | <0.0001 | |
Prosight Management Lp | $7.54M | 1.54 | 3.66M | +510.51% | +$6.3M | 2.1 | |
PFM Health Sciences | $5.22M | 1.07 | 2.54M | -1.57% | -$83,242.54 | 0.14 | |
Sio Capital Management LLC | $5M | 1.02 | 2.43M | New | +$5M | 1.77 | |
Bank of America | $4.53M | 0.92 | 2.2M | +202.66% | +$3.03M | <0.0001 | |
Schroder Investment Management Group | $3.97M | 0.81 | 1.93M | 0% | +$0 | 0.01 | |
Geode Capital Management | $3.9M | 0.8 | 1.89M | +4.39% | +$164,060.84 | <0.0001 | |
State Street | $3.44M | 0.7 | 1.67M | +0.32% | +$11,084.86 | <0.0001 | |
Renaissance Technologies | $3.36M | 0.69 | 1.63M | -18.77% | -$776,391.82 | 0.01 | |
Goldman Sachs | $3.26M | 0.67 | 1.58M | +21.97% | +$587,046.45 | <0.01 | |
Cvi Holdings Llc | $3M | 0.61 | 1.46M | New | +$3M | 3.1 | |
Millennium Management LLC | $2.38M | 0.49 | 1.15M | -22.26% | -$680,784.74 | <0.01 | |
Point72 Asset Management | $2.26M | 0.46 | 1.1M | New | +$2.26M | <0.01 | |
Two Sigma | $2.21M | 0.45 | 1.07M | +7.43% | +$152,722.20 | <0.01 | |
Two Sigma Advisers LP | $2.13M | 0.44 | 1.04M | +65.35% | +$843,364.00 | <0.01 | |
EDBI Pte Ltd | $1.83M | 0.37 | 888,888 | 0% | +$0 | 2.08 | |
Woodline Partners LP | $1.84M | 0.37 | 890,793 | -3.08% | -$58,351.57 | 0.02 | |
Citadel Advisors LLC | $1.72M | 0.35 | 837,314 | -61.01% | -$2.7M | <0.01 | |
Nuveen | $1.42M | 0.29 | 690,201 | -42.48% | -$1.05M | <0.0001 | |
Charles Schwab | $1.37M | 0.28 | 663,870 | +2.11% | +$28,294.10 | <0.0001 | |
Northern Trust | $1.36M | 0.28 | 662,486 | -5.48% | -$79,167.85 | <0.0001 | |
Morgan Stanley | $1.36M | 0.28 | 658,225 | -4.86% | -$69,193.37 | <0.0001 | |
Gsa Capital Partners Llp | $1.17M | 0.24 | 569,039 | -14.79% | -$203,510.34 | 0.09 | |
Acadian Asset Management | $713,000.00 | 0.15 | 346,953 | +286.45% | +$528,501.16 | <0.01 | |
D. E. Shaw & Co. | $660,691.00 | 0.14 | 320,724 | +213.69% | +$450,070.56 | <0.01 | |
Dimensional Fund Advisors | $659,737.00 | 0.14 | 320,261 | -14.87% | -$115,209.51 | <0.0001 | |
BNY Mellon | $536,962.00 | 0.11 | 260,661 | -7.92% | -$46,183.17 | <0.0001 | |
ExodusPoint Capital Management, LP | $514,000.00 | 0.11 | 249,518 | New | +$514,000.00 | 0.01 | |
Regents Of The University Of California | $486,646.00 | 0.1 | 236,236 | 0% | +$0 | 0.14 | |
Xtx Topco Ltd | $470,354.00 | 0.1 | 228,327 | -2.69% | -$13,015.09 | 0.03 | |
Silverarc Capital Management Llc | $461,121.00 | 0.09 | 223,845 | New | +$461,121.00 | 0.14 | |
IPG INVESTMENT ADVISORS, LLC | $427,388.00 | 0.09 | 207,470 | New | +$427,388.00 | 0.09 | |
Pennant Capital Management Llc | $342,372.00 | 0.07 | 166,200 | 0% | +$0 | 0.05 | |
Connor Clark & Lunn Investment Management Ltd | $305,051.00 | 0.06 | 148,083 | +1.44% | +$4,319.82 | <0.01 | |
Fidelity Investments | $285,621.00 | 0.06 | 138,651 | +139.33% | +$166,281.11 | <0.0001 | |
Exchange Traded Concepts, LLC | $282,195.00 | 0.06 | 136,988 | +152.1% | +$170,256.77 | 0.01 | |
AQR Capital | $251,654.00 | 0.05 | 122,162 | New | +$251,654.00 | <0.0001 | |
RhumbLine Advisers | $250,302.00 | 0.05 | 121,509 | +3.32% | +$8,039.97 | <0.0001 | |
AllianceBernstein | $243,719.00 | 0.05 | 118,310 | 0% | +$0 | <0.0001 | |
Jane Street Capital | $237,399.00 | 0.05 | 115,242 | -56.75% | -$311,497.35 | <0.0001 | |
Pale Fire Capital Se | $230,526.00 | 0.05 | 111,906 | -39.87% | -$152,841.46 | <0.01 | |
Susquehanna Fundamental Investments Llc | $215,663.00 | 0.04 | 104,691 | New | +$215,663.00 | 0.01 | |
Tang Capital Management, LLC | $206,000.00 | 0.04 | 100,000 | -33.33% | -$103,000.00 | <0.01 | |
Walleye Capital | $195,861.00 | 0.04 | 95,078 | -31.79% | -$91,260.21 | <0.01 | |
Denali Advisors | $187,872.00 | 0.04 | 91,200 | 0% | +$0 | 0.06 | |
American Century Investments | $169,929.00 | 0.04 | 82,490 | +36.72% | +$45,641.25 | <0.0001 |